Heron Therapeutics
HRTX
HRTX
174 hedge funds and large institutions have $321M invested in Heron Therapeutics in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 57 increasing their positions, 55 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
35% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 26
48% less capital invested
Capital invested by funds: $621M → $321M (-$299M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
174
Holding in Top 10
1
Calls
$1.19M
Puts
$232K
Top Buyers
| 1 | +$28.3M | |
| 2 | +$9.5M | |
| 3 | +$2.35M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$2.12M |
| 5 |
BlackRock
New York
|
+$1.78M |
Top Sellers
| 1 | -$20.1M | |
| 2 | -$5.5M | |
| 3 | -$3.64M | |
| 4 |
Goldman Sachs
New York
|
-$2.8M |
| 5 |
Millennium Management
New York
|
-$2.71M |